Parallax Volatility Advisers, L.P. Provention Bio, Inc. Transaction History

Parallax Volatility Advisers, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.7 - $24.21 $43,737 - $158,042	6,528 Added 33.22%	26,178 $630,000
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $15,946 - $37,290	3,528 Added 21.88%	19,650 $207,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $4,534 - $7,429	1,322 Added 8.93%	16,122 $73,000
Q2 2022 Aug 15, 2022	BUY	$3.65 - $7.3 $54,020 - $108,040	14,800 New	14,800 $59,000
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $168,689 - $223,008	30,177 New	30,177 $170,000
Q4 2021 Feb 14, 2022	SELL	$5.59 - $7.39 $168,689 - $223,008	-30,177 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.66 - $8.33 $747 - $1,099	-132 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $885 - $1,457	132 New	132 $1,000
Q1 2021 May 14, 2021	SELL	$10.12 - $19.45 $26,463 - $50,861	-2,615 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.12 - $19.45 $26,463 - $50,861	2,615 New	2,615 $27,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.